Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (103)

71

Telaprevir for retreatment of HCV infection

enthalten in: The New England journal of medicine | 2011

von Zeuzem, S. | Andreone, P. | Pol, S. | +123

CommentIn: J Hepatol. 2011 Dec;55(6):1457-60. - PMID 21835142

72

Telaprevir for Retreatment of HCV Infection

enthalten in: The New England journal of medicine | 2011

von Zeuzem, S. | Andreone, P. | Pol, S. | +22

73

Telaprevir-Based Regimen in Genotype 1 Hepatitis C Virus-Infected Patients With Prior Null Response, Partial Response or Relapse to Peginterferon/Ribavirin: REALIZE Trial Final Results

enthalten in: Gastroenterology | 2011

von Pockros, P. | Zeuzem, S. | Lawitz, E. | +13

74

Similar SVR Rates in IL28B CC, CT or TT Prior Relapser, Partial- or Null-Responder Patients Treated With Telaprevir/Peginterferon/Ribavirin: Retrospective Analysis of the Realize Study

enthalten in: Gastroenterology | 2011

von Younossi, Z. | Aerssens, J. | Pol, S. | +14

75

Subanalyses of the Telaprevir Lead-in ARM in the Realize Study: Response at Week 4 is Not a Substitute for Prior Null Response Categorization

enthalten in: Gastroenterology | 2011

von Lawitz, E. | Foster, G. | Zeuzem, S. | +13

76

Modeling, Clinical and Virology Data From Phase 2 and 3 Studies Support 12-Week Telaprevir Duration in Combination With 24- or 48-Week Peginterferon/Ribavirin

enthalten in: Gastroenterology | 2011

von Adiwijaya, B. | Kieffer, T. | Bartels, D. | +8

77

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study : 96-week analysis

enthalten in: Antiviral therapy | 2011

von Lathouwers, E. | De Meyer, S. | Dierynck, I. | +4

78

Short communication : activity of etravirine on different HIV type 1 subtypes: in vitro susceptibility in treatment-naive patients and week 48 pooled DUET study data

enthalten in: AIDS research and human retroviruses | 2010

von Vingerhoets, J. | Azijn, H. | Tambuyzer, L. | +7

79

Short Communication: Activity of Etravirine on Different HIV Type 1 Subtypes: In Vitro Susceptibility in Treatment-Naive Patients and Week 48 Pooled DUET Study Data

enthalten in: Aids research and human retroviruses | 2010

von Vingerhoets, J. | Azijn, H. | Tambuyzer, L. | +7

80

Etravirine limits the emergence of darunavir and other protease inhibitor resistance-associated mutations in the DUET trials

enthalten in: AIDS (London, England) | 2010

von Peeters, M. | Vingerhoets, J. | Tambuyzer, L. | +4